Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease
Jae Jung Lee, Jee Hyun Ham, Phil Hyu Lee, Young H. Sohn
JMD. 2015;8(3):130-135.   Published online 2015 Sep 10     DOI: https://doi.org/10.14802/jmd.15031
Citations to this article as recorded by Crossref logo
Lack of consistent sex differences in d-amphetamine-induced dopamine release measured with [18F]fallypride PET
Christopher T. Smith, Linh C. Dang, Leah L. Burgess, Scott F. Perkins, M. Danica San Juan, Darcy K. Smith, Ronald L. Cowan, Nam T. Le, Robert M. Kessler, Gregory R. Samanez-Larkin, David H. Zald
Psychopharmacology.2019; 236(2): 581.     CrossRef
Predictive clinical factors for penetration and aspiration in Parkinson's disease
Julie Cläre Nienstedt, Moritz Bihler, Almut Niessen, Rosemarie Plaetke, Monika Pötter‐Nerger, Christian Gerloff, Carsten Buhmann, Christina Pflug
Neurogastroenterology & Motility.2019; 31(3): e13524.     CrossRef
Does the Side Onset of Parkinson’s Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
Seok Jong Chung, Han Soo Yoo, Hye Sun Lee, Phil Hyu Lee, Young H. Sohn
Journal of Parkinson's Disease.2019; 9(1): 241.     CrossRef
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect
Patrik Fazio, Martin Schain, Ladislav Mrzljak, Nahid Amini, Sangram Nag, Nabil Al-Tawil, Cheryl J. Fitzer-Attas, Juliana Bronzova, Bernhard Landwehrmeyer, Cristina Sampaio, Christer Halldin, Andrea Varrone
NeuroImage.2017; 152: 330.     CrossRef
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells
Barbara Pavan, Antonio Capuzzo, Alessandro Dalpiaz
Drug Discovery Today.2017; 22(7): 1123.     CrossRef
Gender differences in Parkinson's disease: A clinical perspective
D. Georgiev, K. Hamberg, M. Hariz, L. Forsgren, G.-M. Hariz
Acta Neurologica Scandinavica.2017; 136(6): 570.     CrossRef
The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET
Fernando Caravaggio, Jun Ku Chung, Eric Plitman, Isabelle Boileau, Philip Gerretsen, Julia Kim, Yusuke Iwata, Raihaan Patel, M. Mallar Chakravarty, Gary Remington, Ariel Graff-Guerrero
Human Brain Mapping.2017; 38(11): 5519.     CrossRef
Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson’s disease in the North-eastern Han Chinese population
Xiaoyuan Li, Li Xue, Jinfang Sun, Yanping Sun, Anmu Xie
Neuroscience Letters.2017; 656: 72.     CrossRef
Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females
Fernando Caravaggio, Eric Plitman, Jun Ku Chung, Philip Gerretsen, Julia Kim, Yusuke Iwata, Mallar Chakravarty, Gary Remington, Ariel Graff-Guerrero
European Journal of Neuroscience.2017; 46(7): 2253.     CrossRef
Does smoking impact dopamine neuronal loss in de novo Parkinson disease?
Yoonju Lee, Jungsu S. Oh, Seok Jong Chung, Su Jin Chung, Soo-Jong Kim, Chung Mo Nam, Phil Hyu Lee, Jae Seung Kim, Young H. Sohn
Annals of Neurology.2017; 82(5): 850.     CrossRef
The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients
Wioletta Pawlukowska, Karolina Skonieczna-Żydecka, Iwona Rotter, Krystyna Honczarenko, Przemysław Nowacki
BMC Neurology.2017;[Epub]     CrossRef
Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease
Zhongping Lily Mao, Nishit B. Modi
The Journal of Clinical Pharmacology.2016; 56(8): 974.     CrossRef